Jan Björk

3.0k total citations
55 papers, 1.8k citations indexed

About

Jan Björk is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Jan Björk has authored 55 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pathology and Forensic Medicine, 19 papers in Genetics and 18 papers in Oncology. Recurrent topics in Jan Björk's work include Genetic factors in colorectal cancer (33 papers), Microscopic Colitis (14 papers) and Inflammatory Bowel Disease (12 papers). Jan Björk is often cited by papers focused on Genetic factors in colorectal cancer (33 papers), Microscopic Colitis (14 papers) and Inflammatory Bowel Disease (12 papers). Jan Björk collaborates with scholars based in Sweden, Netherlands and Finland. Jan Björk's co-authors include Margareta Nordling, Heikki Järvinen, Yvonne Engwall, Hans F. A. Vasen, Rolf Hultcrantz, Lennart Iselius, Anna Rohlin, S Bülow, Tom Öresland and Steffen Bülow and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Jan Björk

52 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Björk Sweden 25 911 733 545 495 350 55 1.8k
Victoria Murday United Kingdom 20 457 0.5× 411 0.6× 805 1.5× 191 0.4× 107 0.3× 35 1.9k
Melyssa Aronson Canada 24 2.1k 2.3× 1.5k 2.0× 490 0.9× 460 0.9× 214 0.6× 73 2.8k
James Harraway Australia 12 452 0.5× 236 0.3× 283 0.5× 448 0.9× 49 0.1× 26 1.5k
Paula Marincola Smith United States 20 292 0.3× 741 1.0× 101 0.2× 101 0.2× 456 1.3× 64 1.8k
Lizet E. van der Kolk Netherlands 17 337 0.4× 322 0.4× 359 0.7× 82 0.2× 65 0.2× 33 1.3k
Victoria Wang United States 22 676 0.7× 1.0k 1.4× 175 0.3× 117 0.2× 446 1.3× 34 2.1k
Benedicte A. Lie Norway 22 235 0.3× 137 0.2× 300 0.6× 269 0.5× 266 0.8× 35 1.4k
Robert S. Wildin United States 19 91 0.1× 312 0.4× 794 1.5× 235 0.5× 120 0.3× 31 3.0k
Kristin G. Monaghan United States 18 202 0.2× 88 0.1× 693 1.3× 333 0.7× 97 0.3× 29 2.0k
John B. Harley United States 23 355 0.4× 317 0.4× 256 0.5× 58 0.1× 188 0.5× 36 2.2k

Countries citing papers authored by Jan Björk

Since Specialization
Citations

This map shows the geographic impact of Jan Björk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Björk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Björk more than expected).

Fields of papers citing papers by Jan Björk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Björk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Björk. The network helps show where Jan Björk may publish in the future.

Co-authorship network of co-authors of Jan Björk

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Björk. A scholar is included among the top collaborators of Jan Björk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Björk. Jan Björk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Björk, Jan, et al.. (2024). Quality of endoscopic surveillance of Lynch syndrome patients in a Swedish cohort. SHILAP Revista de lepidopterología. 12(7). E854–E860.
2.
3.
Björk, Jan, et al.. (2021). Room for improvement: One third of Lynch syndrome patients presenting for genetic testing in a highly specialised centre in Stockholm already have cancer. Hereditary Cancer in Clinical Practice. 19(1). 18–18. 5 indexed citations
4.
Eriksson, Carl, Susanna Jäghult, Jan Björk, et al.. (2018). Clinical effectiveness of golimumab in Crohn’s disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG). Scandinavian Journal of Gastroenterology. 53(10-11). 1257–1263. 8 indexed citations
5.
Rohlin, Anna, Eva Rambech, Anders Kvist, et al.. (2016). Expanding the genotype–phenotype spectrum in hereditary colorectal cancer by gene panel testing. Familial Cancer. 16(2). 195–203. 45 indexed citations
6.
Ekbom, Anders, et al.. (2015). Microscopic colitis: a descriptive clinical cohort study of 795 patients with collagenous and lymphocytic colitis. Scandinavian Journal of Gastroenterology. 51(5). 556–562. 52 indexed citations
7.
Magnuson, Anders, Jan Björk, Cecilia Benoni, et al.. (2013). Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients. Alimentary Pharmacology & Therapeutics. 38(4). 377–387. 64 indexed citations
8.
Bülow, S, I. J. Christensen, Jan Björk, et al.. (2011). Duodenal surveillance improves the prognosis after duodenal cancer in familial adenomatous polyposis. Colorectal Disease. 14(8). 947–952. 52 indexed citations
9.
Moradi, Tahereh, Gloria Gridley, Jan Björk, et al.. (2008). Occupational physical activity and risk for cancer of the colon and rectum in Sweden among men and women by anatomic subsite. European Journal of Cancer Prevention. 17(3). 201–208. 48 indexed citations
10.
Kanter-Smoler, Gunilla, Anna Rohlin, Yvonne Engwall, et al.. (2008). Clinical characterization and the mutation spectrum in Swedish adenomatous polyposis families. BMC Medicine. 6(1). 10–10. 36 indexed citations
11.
Bülow, Steffen, et al.. (2008). Colectomy and Ileorectal Anastomosis is still an Option for Selected Patients with Familial Adenomatous Polyposis. Diseases of the Colon & Rectum. 51(9). 1318–1323. 42 indexed citations
12.
Kanter-Smoler, Gunilla, Jan Björk, Yvonne Engwall, et al.. (2006). Novel Findings in Swedish Patients With MYH-Associated Polyposis: Mutation Detection and Clinical Characterization. Clinical Gastroenterology and Hepatology. 4(4). 499–506. 22 indexed citations
13.
Meuller, Johan, Gunilla Kanter-Smoler, Anders O.H. Nygren, et al.. (2004). Identification of Genomic Deletions of the APC Gene in Familial Adenomatous Polyposis by Two Independent Quantitative Techniques. Genetic Testing. 8(3). 248–256. 20 indexed citations
14.
Reinders, Claudia I., Per M. Hellström, Jan Björk, Eddie Weitzberg, & Jon O. Lundberg. (2004). Effect of intravenous L‐NMMA on nitric oxide production in collagenous colitis. Scandinavian Journal of Gastroenterology. 39(1). 32–36. 13 indexed citations
15.
Vasen, Hans F. A., Peter van Duijvendijk, Erik Buskens, et al.. (2001). Decision analysis in the surgical treatment of patients with familial adenomatous polyposis: a Dutch-Scandinavian collaborative study including 659 patients. Gut. 49(2). 231–235. 53 indexed citations
16.
Björk, Jan, Lennart Iselius, Annika Bergman, et al.. (2001). Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: Cumulative risks and APC gene mutations. Gastroenterology. 121(5). 1127–1135. 174 indexed citations
17.
Fischer, Heléne, Sima Salahshor, Roger Stenling, et al.. (2001). COL11A1 in FAP polyps and in sporadic colorectal tumors. BMC Cancer. 1(1). 17–17. 47 indexed citations
18.
Vasen, Hans F. A., et al.. (2000). Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis. Gastroenterology. 119(6). 1454–1460. 105 indexed citations
19.
20.
Rubio-Terrés, Carlos, Lena Kanter, Jan Björk, Bertil Poppen, & Lynn Bry. (1996). Paneth Cell‐rich Flat Adenoma of the Rectum: Report of a Case. Japanese Journal of Cancer Research. 87(1). 109–112. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victoria Murday Breakdown of academic impact, for papers by Melyssa Aronson Breakdown of academic impact, for papers by James Harraway Breakdown of academic impact, for papers by Paula Marincola Smith Breakdown of academic impact, for papers by Lizet E. van der Kolk Breakdown of academic impact, for papers by Victoria Wang Breakdown of academic impact, for papers by Benedicte A. Lie Breakdown of academic impact, for papers by Robert S. Wildin Breakdown of academic impact, for papers by Kristin G. Monaghan Breakdown of academic impact, for papers by John B. Harley
Rankless by CCL
2026